Psychomotor Vigilance Performance in Participants with Excessive Daytime Sleepiness in Obstructive Sleep Apnea or Narcolepsy Compared with SAFTE-FAST Model Predictions

INTRODUCTION: Excessive daytime sleepiness (EDS) associated with narcolepsy or obstructive sleep apnea (OSA) can impair vigilance/attention. Solriamfetol, a dopamine/norepinephrine reuptake inhibitor, is approved to treat EDS associated with narcolepsy (75–150 mg/day) or OSA (37.5–150 mg/day). The a...

Descripción completa

Detalles Bibliográficos
Autores principales: Devine, Jaime K., Schwartz, Lindsay, Hursh, Steven, Asin, Jerryll, de Vries, Nicolaas, Vonk, Patty E., Vermeeren, Annemiek, Donjacour, Claire E. H. M., Vinckenbosch, Frederick, Ramaekers, Johannes G., Janssen, Hennie, Wang, Grace, Chen, Dan, Carter, Lawrence P., Overeem, Sebastiaan, Lammers, Gert Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837359/
https://www.ncbi.nlm.nih.gov/pubmed/36494591
http://dx.doi.org/10.1007/s40120-022-00425-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837359/
https://www.ncbi.nlm.nih.gov/pubmed/36494591
http://dx.doi.org/10.1007/s40120-022-00425-w

Ejemplares similares